EAPH - Easton Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5112.46k
Enterprise Value 33.46M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)3.70
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Trading Information

Stock Price History

Beta (3Y Monthly) -2.93
52-Week Change 3-78.77%
S&P500 52-Week Change 30.90%
52 Week High 30.0202
52 Week Low 30.0025
50-Day Moving Average 30.0041
200-Day Moving Average 30.0071

Share Statistics

Avg Vol (3 month) 32.88M
Avg Vol (10 day) 32.43M
Shares Outstanding 5N/A
Float N/A
% Held by Insiders 10.00%
% Held by Institutions 10.01%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 23000/1
Last Split Date 3Apr 30, 2009

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2015
Most Recent Quarter (mrq)Mar 31, 2016

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-526.78k
Diluted EPS (ttm)-0.0010
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.81k
Total Cash Per Share (mrq)0
Total Debt (mrq)15.4k
Total Debt/Equity (mrq)1.21
Current Ratio (mrq)2.28
Book Value Per Share (mrq)0.00

Cash Flow Statement

Operating Cash Flow (ttm)-155.6k
Levered Free Cash Flow (ttm)N/A